| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-3156.2004.01209.X |
| P8608 | Fatcat ID | release_urwh3dahzzhjpdhnzcuylcp3zu |
| P698 | PubMed publication ID | 15078275 |
| P5875 | ResearchGate publication ID | 8624922 |
| P50 | author | David H. Peters | Q37379084 |
| P2093 | author name string | Traci Phillips | |
| P2860 | cites work | Ten years of NGDO action against river blindness | Q34959674 |
| Eliminating onchocerciasis as a public health problem: the beginning of the end. | Q35589970 | ||
| The governance and management of effective community health partnerships: a typology for research, policy, and practice | Q41753806 | ||
| Partnership and promise: evolution of the African river-blindness campaigns | Q44039379 | ||
| Mectizan as a stimulus for development of novel partnerships: the international organization's perspective | Q46515637 | ||
| Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview | Q46562188 | ||
| The Onchocerciasis Elimination Program for the Americas: a history of partnership. | Q52565665 | ||
| Community perspective on Mectizan s role as a catalyst for the formation of novel partnerships | Q99760760 | ||
| The Mectizan Donation Programme a 10 year report | Q99760766 | ||
| Corporate donations | Q99760768 | ||
| Partnerships between non governmental development organizations | Q99760801 | ||
| The donation of Mectizan | Q99760815 | ||
| P433 | issue | 4 | |
| P304 | page(s) | A4-15 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Mectizan Donation Program: evaluation of a public-private partnership | |
| P478 | volume | 9 |
| Q33894321 | Application of nanotechnologies for improved immune response against infectious diseases in the developing world |
| Q37394764 | Assessment of the scope and practice of evaluation among medical donation programs |
| Q39559607 | Doing well while fighting river blindness: the alignment of a corporate drug donation programme with responsibilities to shareholders |
| Q92685009 | Evaluation of pharmaceutical industry-led access programmes: a standardised framework |
| Q51941985 | Global health partnerships in practice: taking stock of the GAVI Alliance's new investment in health systems strengthening. |
| Q33630928 | Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination |
| Q57286135 | Intersectoral collaboration for the prevention and control of vector borne diseases to support the implementation of a global strategy: A systematic review |
| Q36320403 | Ivermectin and onchocerciasis: is it all solved? |
| Q33305360 | Ivermectin resistance in Onchocerca volvulus: toward a genetic basis |
| Q36914039 | Neglected diseases, civil conflicts, and the right to health |
| Q54262173 | Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status. |
| Q39215008 | Optimizing in-kind drug donations for Tanzania-a case study |
| Q39561094 | Orphan drug legislation: lessons for neglected tropical diseases |
| Q37683142 | Programmes, partnerships, and governance for elimination and control of neglected tropical diseases |
| Q93388978 | Public-private partnership (PPP) development: Toward building a PPP framework for healthy eating |
| Q37085810 | Public-private partnership as a solution for integrating genetic services into health care of countries with low and middle incomes |
| Q36320399 | Public-private partnerships in blindness prevention: reaching beyond the eye. |
| Q34576815 | Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program |
| Q90215687 | Review on medicinal plants and natural compounds as anti-Onchocerca agents |
| Q37234648 | The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control |
Search more.